• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

计划进行心脏介入治疗的成年黏多糖贮积症患者的术前注意事项。

Pre-operative Considerations in Adult Mucopolysaccharidosis Patients Planned for Cardiac Intervention.

作者信息

Cross Benjamin, Stepien Karolina M, Gadepalli Chaitanya, Kharabish Ahmed, Woolfson Peter, Tol Govind, Jenkins Petra

机构信息

Adult Congenital Heart Disease Department, Liverpool Heart and Chest Hospital, Liverpool, United Kingdom.

Adult Inherited Metabolic Diseases Department, Salford Royal NHS Foundation Trust, Salford, United Kingdom.

出版信息

Front Cardiovasc Med. 2022 Apr 4;9:851016. doi: 10.3389/fcvm.2022.851016. eCollection 2022.

DOI:10.3389/fcvm.2022.851016
PMID:35445089
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9013828/
Abstract

Mucopolysaccharidoses (MPS) are rare lysosomal storage diseases characterized by multiorgan involvement and shortened longevity. Due to advances in therapies such as enzyme replacement therapy and haematopoietic stem cell therapy, life expectancy has increased posing newer challenges to patients and health professionals. One such challenge is cardiovascular manifestations of MPS, which can be life limiting and cause reduction in quality of life. Any cardiovascular intervention mandates comprehensive, multi-systemic work-up by specialist teams to optimize outcome. We highlight the importance of multidisciplinary evaluation of adult MPS patients requiring cardiovascular intervention. Clinical assessments and investigations are discussed, with a focus on the cardiac, anesthetic, airway, respiratory, radiological and psychosocial factors.

摘要

黏多糖贮积症（MPS）是罕见的溶酶体贮积病，其特征为多器官受累且寿命缩短。由于酶替代疗法和造血干细胞疗法等治疗方法的进步，患者预期寿命有所增加，这给患者和医护人员带来了新的挑战。其中一个挑战就是MPS的心血管表现，它可能会限制生命并导致生活质量下降。任何心血管干预都需要专业团队进行全面、多系统的检查，以优化治疗结果。我们强调了对需要进行心血管干预的成年MPS患者进行多学科评估的重要性。本文讨论了临床评估和检查，重点关注心脏、麻醉、气道、呼吸、放射学和社会心理因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fc/9013828/8f4529681066/fcvm-09-851016-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fc/9013828/8f4529681066/fcvm-09-851016-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5fc/9013828/8f4529681066/fcvm-09-851016-g0001.jpg

相似文献

1
Pre-operative Considerations in Adult Mucopolysaccharidosis Patients Planned for Cardiac Intervention.计划进行心脏介入治疗的成年黏多糖贮积症患者的术前注意事项。
Front Cardiovasc Med. 2022 Apr 4;9:851016. doi: 10.3389/fcvm.2022.851016. eCollection 2022.
2
The landscape of Mucopolysaccharidosis in Southern and Eastern European countries: a survey from 19 specialistic centers.南欧和东欧国家黏多糖贮积症的概况：来自 19 个专业中心的调查。
Orphanet J Rare Dis. 2022 Mar 24;17(1):136. doi: 10.1186/s13023-022-02285-x.
3
Mucopolysaccharidoses I and II: Brief Review of Therapeutic Options and Supportive/Palliative Therapies.黏多糖贮积症 I 型和 II 型：治疗选择和支持/姑息疗法的简要综述。
Biomed Res Int. 2020 Dec 4;2020:2408402. doi: 10.1155/2020/2408402. eCollection 2020.
4
Unique medical issues in adult patients with mucopolysaccharidoses.成年黏多糖贮积症患者的独特医学问题。
Eur J Intern Med. 2016 Oct;34:2-10. doi: 10.1016/j.ejim.2016.05.017. Epub 2016 Jun 11.
5
Non-cardiac Manifestations in Adult Patients With Mucopolysaccharidosis.成人黏多糖贮积症患者的非心脏表现
Front Cardiovasc Med. 2022 Mar 7;9:839391. doi: 10.3389/fcvm.2022.839391. eCollection 2022.
6
[Enzyme replacement therapy for mucopolysaccharidoses I, II and VI: recommendations from a group of Brazilian F experts].[黏多糖贮积症 I、II 和 VI 的酶替代疗法：一组巴西专家的建议]
Rev Assoc Med Bras (1992). 2010 May-Jun;56(3):271-7. doi: 10.1590/s0104-42302010000300009.
7
Airway and Anaesthetic Management of Adult Patients with Mucopolysaccharidoses Undergoing Cardiac Surgery.成年黏多糖贮积症患者心脏手术的气道与麻醉管理
J Clin Med. 2024 Feb 28;13(5):1366. doi: 10.3390/jcm13051366.
8
Characterization of pulmonary function impairments in patients with mucopolysaccharidoses--changes with age and treatment.黏多糖贮积症患者肺功能损害的特征——随年龄和治疗的变化
Pediatr Pulmonol. 2014 Mar;49(3):277-84. doi: 10.1002/ppul.22774. Epub 2013 Feb 8.
9
Mucopolysaccharidoses and the eye.黏多糖贮积症与眼睛。
Surv Ophthalmol. 2006 Jan-Feb;51(1):1-17. doi: 10.1016/j.survophthal.2005.11.007.
10
Recommendations for the management of MPS VI: systematic evidence- and consensus-based guidance.MPS VI 管理建议：基于系统证据和共识的指南。
Orphanet J Rare Dis. 2019 May 29;14(1):118. doi: 10.1186/s13023-019-1080-y.

引用本文的文献

1
Airway and Anaesthetic Management of Adult Patients with Mucopolysaccharidoses Undergoing Cardiac Surgery.成年黏多糖贮积症患者心脏手术的气道与麻醉管理
J Clin Med. 2024 Feb 28;13(5):1366. doi: 10.3390/jcm13051366.

本文引用的文献

1
Transcatheter aortic valve implantation for severe aortic stenosis in a patient with mucopolysaccharidosis type II (Hunter syndrome) accompanied by severe airway obstruction.经导管主动脉瓣植入术治疗伴有严重气道梗阻的II型黏多糖贮积症（亨特综合征）患者的严重主动脉瓣狭窄。
J Cardiol Cases. 2021 Jul 3;25(1):49-51. doi: 10.1016/j.jccase.2021.06.008. eCollection 2022 Jan.
2
Airway Abnormalities in Adult Mucopolysaccharidosis and Development of Salford Mucopolysaccharidosis Airway Score.成人黏多糖贮积症的气道异常与索尔福德黏多糖贮积症气道评分的发展
J Clin Med. 2021 Jul 24;10(15):3275. doi: 10.3390/jcm10153275.
3
Double valve replacement in a patient with Maroteaux - Lamy syndrome as an ultimate team challenge.
马罗托-拉米综合征患者的双瓣膜置换术：终极团队挑战。
J Cardiothorac Surg. 2021 May 24;16(1):141. doi: 10.1186/s13019-021-01530-x.
4
The natural history of neurocognition in MPS disorders: A review.MPS 疾病的神经认知自然史：综述。
Mol Genet Metab. 2021 May;133(1):8-34. doi: 10.1016/j.ymgme.2021.03.002. Epub 2021 Mar 11.
5
Natural progression of cardiac features and long-term effects of enzyme replacement therapy in Taiwanese patients with mucopolysaccharidosis II.台湾黏多糖贮积症 II 型患者心脏特征的自然进程和酶替代疗法的长期效果。
Orphanet J Rare Dis. 2021 Feb 23;16(1):99. doi: 10.1186/s13023-021-01743-2.
6
Neonatal heart failure and noncompaction/dilated cardiomyopathy from mucopolysaccharidosis. First description in literature.新生儿心力衰竭与黏多糖贮积症所致的心肌致密化不全/扩张型心肌病。文献首次描述。
Mol Genet Metab Rep. 2021 Jan 29;26:100714. doi: 10.1016/j.ymgmr.2021.100714. eCollection 2021 Mar.
7
Aortic Root Dilatation in Taiwanese Patients with Mucopolysaccharidoses and the Long-Term Effects of Enzyme Replacement Therapy.台湾黏多糖贮积症患者的主动脉根部扩张及酶替代疗法的长期效果
Diagnostics (Basel). 2020 Dec 23;11(1):16. doi: 10.3390/diagnostics11010016.
8
Cardiac manifestations and effects of enzyme replacement therapy for over 10 years in adults with the attenuated form of mucopolysaccharidosis type I.成人I型黏多糖贮积症轻症型患者接受酶替代疗法10余年的心脏表现及影响
Mol Genet Metab Rep. 2020 Oct 20;25:100662. doi: 10.1016/j.ymgmr.2020.100662. eCollection 2020 Dec.
9
Combined valve replacement and aortocoronary bypass in an adult mucopolysaccharidosis type VII patient.在一名成年黏多糖贮积症 VII 型患者中进行联合瓣膜置换和主动脉冠状动脉旁路移植术。
Cardiovasc Pathol. 2021 Jan-Feb;50:107297. doi: 10.1016/j.carpath.2020.107297. Epub 2020 Oct 9.
10
Aortopathies in mouse models of Pompe, Fabry and Mucopolysaccharidosis IIIB lysosomal storage diseases.庞贝病、法布雷病和黏多糖贮积症 IIIB 溶酶体贮积病的小鼠模型中的主动脉病变。
PLoS One. 2020 May 19;15(5):e0233050. doi: 10.1371/journal.pone.0233050. eCollection 2020.